IMNM - CIK 0001472012
The table below shows Immunome Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $653.48M | $143.35M | $98.68M | $20.32M | $49.23M | $39.77M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $660.78M |
| $221.34M |
| $144.70M |
| $22.65M |
| $56.64M |
| $42.89M |
| Property, plant & equipment | $14.64M | $10.11M | $2.07M | $681.00K | $855.00K | $1.53M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $683.19M | $240.24M | $148.54M | $24.05M | $57.92M | $44.52M |
| Accounts payable | $3.34M | $14.19M | $3.31M | $2.40M | $3.08M | $1.19M |
| Total current liabilities | $44.99M | $54.31M | $21.83M | $7.33M | $9.73M | $3.04M |
| Long-term debt | - | - | - | - | $134.00K | $134.00K |
| Total liabilities | $48.84M | $59.08M | $28.66M | $7.39M | $9.74M | $3.18M |
| Retained earnings | -$728.16M | -$515.77M | -$222.81M | -$116.00M | -$79.11M | -$54.39M |
| Total equity | $634.34M | $181.16M | $119.88M | $16.65M | $48.19M | $41.34M |